Morepen Laboratories Management
Management criteria checks 3/4
Morepen Laboratories' CEO is Sushil Suri, appointed in Oct 2000, has a tenure of 23.5 years. total yearly compensation is ₹47.72M, comprised of 91.8% salary and 8.2% bonuses, including company stock and options. directly owns 1.31% of the company’s shares, worth ₹341.72M. The average tenure of the management team and the board of directors is 7.3 years and 18.8 years respectively.
Key information
Sushil Suri
Chief executive officer
₹47.7m
Total compensation
| CEO salary percentage | 91.8% |
| CEO tenure | 23.5yrs |
| CEO ownership | 1.3% |
| Management average tenure | 7.3yrs |
| Board average tenure | 18.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹761m |
| Sep 30 2023 | n/a | n/a | ₹531m |
| Jun 30 2023 | n/a | n/a | ₹477m |
| Mar 31 2023 | ₹48m | ₹44m | ₹387m |
| Dec 31 2022 | n/a | n/a | ₹428m |
| Sep 30 2022 | n/a | n/a | ₹553m |
| Jun 30 2022 | n/a | n/a | ₹768m |
| Mar 31 2022 | ₹91m | ₹87m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹54m | ₹51m | ₹971m |
| Dec 31 2020 | n/a | n/a | ₹814m |
| Sep 30 2020 | n/a | n/a | ₹684m |
| Jun 30 2020 | n/a | n/a | ₹453m |
| Mar 31 2020 | ₹17m | ₹16m | ₹336m |
| Dec 31 2019 | n/a | n/a | ₹331m |
| Sep 30 2019 | n/a | n/a | ₹312m |
| Jun 30 2019 | n/a | n/a | ₹340m |
| Mar 31 2019 | ₹12m | ₹11m | ₹288m |
| Dec 31 2018 | n/a | n/a | ₹252m |
| Sep 30 2018 | n/a | n/a | ₹267m |
| Jun 30 2018 | n/a | n/a | ₹308m |
| Mar 31 2018 | ₹6m | ₹4m | ₹296m |
Compensation vs Market: Sushil's total compensation ($USD572.47K) is above average for companies of similar size in the Indian market ($USD275.93K).
Compensation vs Earnings: Sushil's compensation has been consistent with company performance over the past year.
CEO
Sushil Suri (59 yo)
23.5yrs
Tenure
₹47,718,000
Compensation
Mr. Sushil Suri, B.Sc., FCA has been Managing Director of Morepen Laboratories Limited since October 2000. He has been Chairman of Morepen Laboratories Limited since October 2000 and has been its Director...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 23.5yrs | ₹47.72m | 1.31% ₹ 341.7m | |
| Whole-Time Director | 9.3yrs | ₹18.12m | 1.08% ₹ 281.3m | |
| Chief Financial Officer | 9.7yrs | ₹9.80m | no data | |
| General Manager of Finance & Accounts (Corporate) | no data | no data | no data | |
| General Manager of Process Engineering & Technology Transfer | no data | no data | no data | |
| Manager of Administration | no data | no data | 0.62% ₹ 162.7m | |
| Company Secretary & Compliance Officer | 5.4yrs | ₹1.84m | no data | |
| Functional Head of Talent Acquisition & HRBP | less than a year | no data | no data | |
| Chief Operating Officer of API | less than a year | no data | no data | |
| Head of Medipath Division | no data | no data | 0.45% ₹ 116.3m | |
| Head of International Business Development | no data | no data | no data | |
| Chief Executive Officer of Consumer Division | no data | no data | 0.60% ₹ 155.6m |
7.3yrs
Average Tenure
46.5yo
Average Age
Experienced Management: 500288's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 32.2yrs | ₹47.72m | 1.31% ₹ 341.7m | |
| Whole-Time Director | 4.7yrs | ₹18.12m | 1.08% ₹ 281.3m | |
| Independent Non Executive Director | 31.8yrs | ₹465.00k | no data | |
| Independent Non Executive Director | 18.8yrs | ₹575.00k | no data | |
| Independent Non Executive Director | 18.8yrs | ₹625.00k | no data | |
| Independent Director | 4.7yrs | ₹545.00k | no data | |
| Independent Director | 3.8yrs | ₹375.00k | no data |
18.8yrs
Average Tenure
58yo
Average Age
Experienced Board: 500288's board of directors are seasoned and experienced ( 18.8 years average tenure).